Trial
NCT05216614
Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Washington University School of Medicine
Collaborators
—
Condition
COVID-19
Intervention
Fluvoxamine
Why stopped
Unable to obtain investigational product
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-11